The company said that the drug, listed on the FDA’s Current Drug Shortages list, is available in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system, according to a company news release.
Read the PharMEDium news release about the availability of propofol.
Read more about propofol:
– BCBS of North Carolina Holds Strong on Use of Deep Sedation for Endoscopic Procedures Policy
– ASA Supports DEA Proposal to List Propofol on Schedule IV
– Impact of the Propofol Shortage on Anesthesiologists: Q&A With ASA President Alexander Hannenberg
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
